[
    {
        "content": "* Taro Pharmaceutical Industries Ltd-qtrly \u200dshr $1.30\u200b Source text for Eikon: Further company coverage:",
        "date": "11082017",
        "name": "Taro Pharmaceutical Industries Ltd",
        "news_type": "topStory",
        "symbol": "TARO",
        "title": "BRIEF-Taro Pharmaceutical quarterly earnings per share $1.30 "
    },
    {
        "content": "* Taro Pharmaceutical Industries Ltd - \u200d Uday Baldota has joined company as its chief executive officer (\"CEO\") effective August 28  2017\u200b",
        "date": "09012017",
        "name": "Taro Pharmaceutical Industries Ltd",
        "news_type": "topStory",
        "symbol": "TARO",
        "title": "BRIEF-Taro announces joining of CEO "
    },
    {
        "content": "Aug 9 Indian shares fell for a third consecutive session on Wednesday  dragged down by financial and healthcare stocks  as escalating tensions on the Korean peninsula hit regional markets.",
        "date": "08092017",
        "name": "Taro Pharmaceutical Industries Ltd",
        "news_type": "topStory",
        "symbol": "TARO",
        "title": "Indian shrs fall for 3rd day; US-N.Korea tensions spook investors "
    },
    {
        "content": "* Qtrly net income per ordinary share $1.35 Source text for Eikon: Further company coverage:",
        "date": "08092017",
        "name": "Taro Pharmaceutical Industries Ltd",
        "news_type": "normal",
        "symbol": "TARO",
        "title": "BRIEF-Taro reports quarterly net income per ordinary share $1.35 "
    },
    {
        "content": "* Qtrly earnings per share $2.05 Source text for Eikon: Further company coverage:",
        "date": "05222017",
        "name": "Taro Pharmaceutical Industries Ltd",
        "news_type": "topStory",
        "symbol": "TARO",
        "title": "BRIEF-Taro reports qtrly EPS $2.05 "
    },
    {
        "content": "* Crescita Therapeutics announces agreement with Taro Pharmaceuticals for Pliaglis",
        "date": "04252017",
        "name": "Taro Pharmaceutical Industries Ltd",
        "news_type": "topStory",
        "symbol": "TARO",
        "title": "BRIEF-Crescita Therapeutics announces agreement with Taro Pharmaceuticals for Pliaglis "
    },
    {
        "content": "* Press release - Bellus Health announces the sale of subsidiary Thallion Pharmaceuticals to Taro Pharmaceuticals",
        "date": "03162017",
        "name": "Taro Pharmaceutical Industries Ltd",
        "news_type": "topStory",
        "symbol": "TARO",
        "title": "BRIEF-Bellus Health to sell subsidiary Thallion Pharmaceuticals to Taro Pharmaceuticals "
    },
    {
        "content": "* Taro Pharmaceutical Industries Ltd qtrly net income per ordinary share from continuing operations attributable to taro $3.42  Source text for Eikon:  Further company coverage:",
        "date": "02092017",
        "name": "Taro Pharmaceutical Industries Ltd",
        "news_type": "topStory",
        "symbol": "TARO",
        "title": "BRIEF-Taro posts quarterly sales of $220.4 million "
    },
    {
        "content": "* Taro Pharmaceutical Industries Ltd-  Uday Baldota as chief executive officer",
        "date": "11222016",
        "name": "Taro Pharmaceutical Industries Ltd",
        "news_type": "topStory",
        "symbol": "TARO",
        "title": "BRIEF-Taro Pharmaceutical Industries names Uday Baldota CEO "
    },
    {
        "content": "* Taro Pharmaceutical Industries Ltd - qtrly loss per share $0.00",
        "date": "11082016",
        "name": "Taro Pharmaceutical Industries Ltd",
        "news_type": "topStory",
        "symbol": "TARO",
        "title": "BRIEF-Taro Pharmaceutical Industries qtrly loss per share $0.00 "
    },
    {
        "content": "* Appointment of Mariano Balaguer as vice president  CFO and chief accounting officer  effective today  Source text for Eikon:  Further company coverage:",
        "date": "10032016",
        "name": "Taro Pharmaceutical Industries Ltd",
        "news_type": "topStory",
        "symbol": "TARO",
        "title": "BRIEF-Taro appoints new chief financial officer "
    },
    {
        "content": "WASHINGTON Taro Pharmaceutical Industries Ltd and two of its senior officers received grand jury subpoenas last week in connection with a federal antitrust investigation into generic drug pricing  the company disclosed.",
        "date": "09112016",
        "name": "Taro Pharmaceutical Industries Ltd",
        "news_type": "topStory",
        "symbol": "TARO",
        "title": "U.S. Justice Department subpoenas Taro over generic drug pricing "
    },
    {
        "content": "WASHINGTON Taro Pharmaceutical Industries Ltd  and two of its senior officers received grand jury subpoenas last week in connection with a federal antitrust investigation into generic drug pricing  the company disclosed.",
        "date": "09122016",
        "name": "Taro Pharmaceutical Industries Ltd",
        "news_type": "topStory",
        "symbol": "TARO",
        "title": "U.S. Justice Department subpoenas Taro over generic drug pricing "
    },
    {
        "content": "WASHINGTON  Sept 11 Taro Pharmaceutical Industries Ltd and two of its senior officers received grand jury subpoenas last week in connection with a federal antitrust investigation into generic drug pricing  the company disclosed.",
        "date": "09112016",
        "name": "Taro Pharmaceutical Industries Ltd",
        "news_type": "normal",
        "symbol": "TARO",
        "title": "UPDATE 1-U.S. Justice Department subpoenas Taro over generic drug pricing "
    },
    {
        "content": "* Quarterly earnings per share $2.59  Source text for Eikon:  Further company coverage:",
        "date": "08102016",
        "name": "Taro Pharmaceutical Industries Ltd",
        "news_type": "topStory",
        "symbol": "TARO",
        "title": "BRIEF-Taro posts qtrly earnings per share $2.59 "
    },
    {
        "content": "* Taro ceo Kal Sundaram to return to Sun Pharma headquarters by the end of 2016",
        "date": "07062016",
        "name": "Taro Pharmaceutical Industries Ltd",
        "news_type": "topStory",
        "symbol": "TARO",
        "title": "BRIEF-Taro Pharma CEO Kal Sundaram to return to Sun Pharma headquarters by the end of 2016 "
    },
    {
        "content": "* Kalb joins Amarin from Taro Pharmaceutical Industries Ltd  Source text for Eikon:  Further company coverage:    (Bengaluru Newsroom: +1 646 223 8780)",
        "date": "06302016",
        "name": "Taro Pharmaceutical Industries Ltd",
        "news_type": "topStory",
        "symbol": "TARO",
        "title": "BRIEF-Amarin appoints Michael Kalb chief financial officer "
    },
    {
        "content": "* Qtrly net sales of $265.1 million  increased $20.9 million  or 8.6%  on relatively flat volumes",
        "date": "05262016",
        "name": "Taro Pharmaceutical Industries Ltd",
        "news_type": "topStory",
        "symbol": "TARO",
        "title": "BRIEF-Taro pharmaceutical industries Q4 shr $2.68 "
    }
]